Synthesis of boronic ester and acid compounds

Patent metadata

Field	Value
Publication number	US-9862745-B2
Application number	US-201614991363-A
Country	US
Kind code	B2
Filing date	Jan 8, 2016
Priority date	Mar 30, 2004
Publication date	Jan 9, 2018
Grant date	Jan 9, 2018

Abstract

The invention relates to the synthesis of boronic ester and acid compounds. More particularly, the invention provides improved synthetic processes for the large-scale production of boronic ester and acid compounds, including the peptide boronic acid proteasome inhibitor bortezomib.

First claim

What is claimed is:

1. A large-scale process for forming a compound of formula (XIV):

or a boronic acid anhydride thereof, comprising the steps:
(aa) coupling a compound of formula (XVIII):

or an acid addition salt thereof, with a compound of formula (XIX):

wherein:
P 1 is a cleavable amino group protecting moiety; and
X is OH or a leaving group;

to form a compound of formula (XX):

wherein P 1 is as defined above, said coupling step (aa) comprising the steps:
(i) coupling the compound of formula (XVIII) with a compound of formula (XIX) wherein X is OH in the presence of 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU) and a tertiary amine in dichloromethane;
(ii) performing a solvent exchange to replace dichloromethane with ethyl acetate; and
(iii) performing an aqueous wash of the ethyl acetate solution;
(bb) removing the protecting group P′ to form a compound of formula (XXI):

or an acid addition salt thereof, said protecting group removing step (bb) comprising the steps:
(i) treating the compound of formula (XX) with HCl in ethyl acetate;
(ii) adding heptane to the reaction mixture; and
(iii) isolating by crystallization the compound of formula (XXI) as its HCl addition salt;
(cc) coupling the compound of formula (XXI) with a reagent of formula (XXII)

wherein X is a OH or a leaving group, to form a compound of formula (XXIII):

said coupling step (cc) comprising the steps:
(i) coupling the compound of formula (XV) with 2-pyrazinecarboxylic acid in the presence of TBTU and a tertiary amine in dichloromethane;
(ii) performing a solvent exchange to replace dichloromethane with ethyl acetate; and
(iii) performing an aqueous wash of the ethyl acetate solution; and
(dd) deprotecting the boronic acid moiety to form the compound of formula (XIV) or a boronic acid anhydride thereof, said deprotecting step (dd) comprising the steps:
(i) providing a biphasic mixture comprising the compound of formula (XXIII), an organic boronic acid acceptor, a lower alkanol, a C 5-8 hydrocarbon solvent, and aqueous mineral acid;
(ii) stirring the biphasic mixture to afford the compound of formula (XIV);
(iii) separating the solvent layers; and
(iv) extracting the compound of formula (XIV), or a boronic acid anhydride thereof, into an organic solvent.

2. The process of claim 1 , wherein step (dd)(iii) comprises the steps:
(1) separating the solvent layers;
(2) adjusting the aqueous layer to basic pH;
(3) washing the aqueous layer with an organic solvent; and
(4) adjusting the aqueous layer to a pH less than about 8.

3. The process of claim 2 , wherein in step (dd)(iv), the compound of formula (XIV), or a boronic acid anhydride thereof, is extracted into dichloromethane, the solvent is exchanged to ethyl acetate, an the compound of formula (XIV), or a boronic acid anhydride thereof, is crystallized by addition of hexane or heptane.

4. The process of claim 3 , wherein addition of hexane or heptane results in crystallization of a cyclic trimeric boronic acid anhydride of formula (XXIV):

Assignees

• Millennium Pharm Inc
• Millennium Pharm Inc

Inventors

• Ammoscato Vince
• Bishop John E
• Chiu Fang-Ting
• Geiser Achim
• Gomez Jean-Marc
• Hett Robert
• Koellner Christoph
• Kulkarni Vithalanand R
• Lo Young
• Munk Stephen
• Pickersgill I Fraser

Classifications

• A61P35/00

  Antineoplastic agents · CPC title

• A61P37/06

  Immunosuppressants, e.g. drugs for graft rejection · CPC title

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• A61P31/18

  for HIV · CPC title

• C07F5/025 Primary

  Boronic and borinic acid compounds · CPC title